Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2015 – results from 1 January to 31 March, 2015
DGAP-News: Veloxis Pharmaceuticals A/S 2015-05-12 / 13:26 --------------------------------------------------------------------- Investor service announcement no. 2/2015 To: NASDAQ OMX Copenhagen Hørsholm, Denmark, 12 May, 2015 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2015 - results from 1 January to 31 March, 2015 Veloxis Pharmaceuticals A/S (OMX: VELO) will announce the Interim Report for the first Quarter 2015 on Wednesday 20 May, 2015 after 05:00 PM CET. Veloxis' Management will host an accompanying conference call to discuss the financial results on Thursday 21 May, 2015 at 3:00 PM CET (Denmark); 2:00 PM GMT (London), 9:00 AM EST (New York), To access the live conference call, please dial one of the following numbers: +45 32 71 16 60 (Denmark) +44 (0) 20 3427 1913 (UK) +1 212 444 0896 (USA) Access code 7709988 Following the conference call, a recording will be available on the company's website http://www.veloxis.com. For more information, please contact: John D. Weinberg Johnny Stilou EVP, Chief Operating Officer EVP, Chief Financial Officer Phone: +1 908 304 3389 Phone: +45 30 53 33 64 Email: jdw@veloxis.com Email: jst@veloxis.com Veloxis Pharmaceuticals A/S (VELO) Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose(R), is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO. For further information, please visit www.veloxis.com. News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-05-12 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Veloxis Pharmaceuticals A/S Denmark ISIN: DK0060048148 End of News DGAP News-Service --------------------------------------------------------------------- 356495 2015-05-12
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden